FRI0416 CHARACTERISTICS AND CAPILLAROSCOPIC FINDINGS OF SYSTEMIC SCLEROSIS PATIENTS WITH SEVERE PERIPHERAL VASCULAR INVOLVEMENT RECEIVING SPECIFIC VASODILATOR TREATMENT
Y. Yalçınkaya, A.U. Ünal, Z. Ertürk, U. Gazel, S. Kaymaz, A. Aksoy, P. Atagündüz, N.İnanç, H. Direskeneli. Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey Background: Severity of peripheral vascular involvement (PVI)is known as an important determinig cause of morbidity in sytemic sclerosis (SSc). Different vasodilating agents have been found to reduce severity and contribute to healing of digital ulcers (DU)in SSc.
Objectives: We aimed to evaluate the characteristics and capillaroscopic patterns of the patients with severe PVI under different vasodilator therapeutic regimens. Methods: The patients were grouped as "severe PVI" if score of PVI is ≥2 (PVT=2,digital pitting scars; PVT=3, digital tip ulcerations and PVT=4, digital gangrene; Medsger) and "non-severe PVI" if score of PVI is ≤1 (PVI=0,no Raynaud's; PVI=1, Raynaud's requiring vasodilators). We included patients with severe PVI who received cyclic iloprost and bosentan and/or sildenafil and compared to non-severe PVI. Nail fold video-capillaroscopy (NVC)was assessed qualitatively (Cutalo et al., early, active and late patterns). Results: Severe PVI group more frequently had diffuse cutaneous form, contractures, lung disease, anti-Scl70 positivity and high acute phase response and exposed to immunosuppressives (table-1). Scores of telangiectasia, skin, activity and severity were lower in non-severe group. NVC late pattern was frequent and early pattern was rare in severe PVI groups. Forty-one% (9/22) of patients received second oral agent for PVI.
Monotherapy and combination groups had similar scores (table-2).
Conclusions: NVC late pattern was frequent in severe PVI group with long disease duration, exposed to intensive immunosuppresives and received specific vasodilators for PVI. Disease activity and severity were higher in severe PVI group. One third of the severe group required oral combination therapy for PVI. Monotherapy and combination groups were similar in terms of severity. NVC is a useful method to monitor digital ischemia and severe organ involvement in SSc. Background: Pulmonary arterial hypertension (PAH) is prominent as a vascular involvement in systemic sclerosis (SSc), which remains a leading cause of death in spite of current best treatments. As the pulmonary vascular disease (PVD) can be well compensated for, more than a half of the pulmonary circulation is impaired before early PAH is detected. Although recent studies focused on molecular basis of the PVD, the underlying mechanisms have not been fully elucidated, especially at the early stage of the disease. Objectives: To detect the subclinical PVD, and to explore the changes in transcriptome of peripheral blood at the early stage of SSc associated PAH. Methods: Total of 74 cases without PAH symptoms (NYHA I) with either Raynaud phenomenon (RP: n=61), skin sclerosis (n=43) or SSc-related autoantibody (anti-RNP: n=10, centromere: n=36, topoisomerase-1: n=2, RNA polymerase III: n=2) were enrolled. To detect the latent PAH, exercise Doppler echocardiography (DE) with Master's two-step stress was carried out. Systolic PAP (sPAP) was determined by maximum velocities of tricuspid regurgitation jets, and exercise induced pulmonary hypertension (exPH) group was segregated from normal response group (exN) with using the definition of a sPAP greater than 40 mm Hg during exercise, or a exercise increase in sPAP by greater than 20 mm
